Upsher-Smith Launches Isotretinoin Capsules
MAPLE GROVE, Minn., June 25, 2021 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Isotretinoin Capsules. Upsher-Smith's product is AB2-rated to the branded product, Absorica® (isotretinoin) capsules.
The isotretinoin capsule market had U.S. sales of approximately $156 million for the 12 months ending April 2021 according to IQVIA.
For questions about ordering, please call Upsher-Smith at 1-800-654-2299.
Please refer to the full Prescribing Information, including Boxed Warning for Isotretinoin Capsules here. You can also call 1-888-650-3789 to obtain a copy of the full Prescribing Information.
You are encouraged to report suspected adverse reactions to Upsher-Smith Laboratories, LLC at 1-855-899-9180 or to the FDA by visiting http://www.fda.gov/medwatch.
Absorica® is a registered trademark of Sun Pharmaceutical Industries, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/upsher-smith-launches-isotretinoin-capsules-301320160.html
SOURCE Upsher-Smith Laboratories, LLC